These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 5836667)
21. Sources of error in heparin therapy of thromboembolic disease. Hattersley PG; Mitsuoka JC; King JH Arch Intern Med; 1980 Sep; 140(9):1173-5. PubMed ID: 7406615 [TBL] [Abstract][Full Text] [Related]
22. Subcutaneous low-molecular-weight heparin fragmin versus intravenous unfractionated heparin in the treatment of acute non massive pulmonary embolism: an open randomized pilot study. Meyer G; Brenot F; Pacouret G; Simonneau G; Gillet Juvin K; Charbonnier B; Sors H Thromb Haemost; 1995 Dec; 74(6):1432-5. PubMed ID: 8772215 [TBL] [Abstract][Full Text] [Related]
23. [Current aspects of the treatment of deep venous thromboses by heparin (author's transl)]. Juillet Y; Morin D; Richard A; Fiessinger JN; Aiach M; Housset E Nouv Presse Med; 1980 Apr; 9(19):1349-52. PubMed ID: 7383849 [TBL] [Abstract][Full Text] [Related]
24. [Indications for thrombolytic agents in venous thrombosis and pulmonary embolism]. Serradimigni A; Romani A; Chiche G; Aubry J; Philip F Rev Prat; 1981 Nov; 31(53):3793-4 passim. PubMed ID: 7313474 [No Abstract] [Full Text] [Related]
31. Antepartum pulmonary emboli. Millard CA R I Med J; 1970 Jul; 53(7):373-5. PubMed ID: 5270284 [No Abstract] [Full Text] [Related]
32. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin. Monreal M; Lafoz E; Olive A; del Rio L; Vedia C Thromb Haemost; 1994 Jan; 71(1):7-11. PubMed ID: 8165649 [TBL] [Abstract][Full Text] [Related]
33. Low molecular weight heparin (dalteparin) is equally effective as unfractionated heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism. Schutgens RE; Esseboom EU; Snijder RJ; Haas FJ; Verzijlbergen F; Nieuwenhuis HK; Lisman T; Biesma DH J Lab Clin Med; 2004 Aug; 144(2):100-7. PubMed ID: 15322504 [TBL] [Abstract][Full Text] [Related]
35. Management of acute deep venous thrombosis. Satiani B Am Fam Physician; 1982 Apr; 25(4):103-9. PubMed ID: 7064760 [No Abstract] [Full Text] [Related]
36. [Intrapulmonary heparin]. Huang SW Zhonghua Jie He He Hu Xi Za Zhi; 1988 Dec; 11(6):370-2. PubMed ID: 3074878 [No Abstract] [Full Text] [Related]
37. The use of prophylactic subcutaneous heparin in patients undergoing hernia repairs. Jourdan M; McColl I Br J Clin Pract; 1984 Sep; 38(9):298-300. PubMed ID: 6477809 [No Abstract] [Full Text] [Related]
38. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis. Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792 [TBL] [Abstract][Full Text] [Related]
39. The successful application of a heparin nomogram in a community hospital. Hollingsworth JA; Rowe BH; Brisebois FJ; Thompson PR; Fabris LM Arch Intern Med; 1995 Oct; 155(19):2095-100. PubMed ID: 7575069 [TBL] [Abstract][Full Text] [Related]
40. Treatment of a patient with an undefined hypercoagulable state with long-term low-molecular-weight heparin. Dobie SA; Ellsworth AJ; Linenberger ML West J Med; 1996 Apr; 164(4):350-3. PubMed ID: 8732743 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]